These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 28286675)

  • 1. Ductal Breast Carcinoma In Situ: Mammographic Features and Its Relation to Prognosis and Tumour Biology in a Population Based Cohort.
    Zhou W; Sollie T; Tot T; Blomqvist C; Abdsaleh S; Liljegren G; Wärnberg F
    Int J Breast Cancer; 2017; 2017():4351319. PubMed ID: 28286675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer with neoductgenesis: histopathological criteria and its correlation with mammographic and tumour features.
    Zhou W; Sollie T; Tot T; Pinder SE; Amini RM; Blomqvist C; Fjällskog ML; Christensson G; Abdsaleh S; Wärnberg F
    Int J Breast Cancer; 2014; 2014():581706. PubMed ID: 25400950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast cancers originating from the major lactiferous ducts and the process of neoductgenesis: Ductal Adenocarcinoma of the Breast, DAB.
    Tabár L; Dean PB; Lee Tucker F; Yen AM; Chang RW; Hsu CY; Smith RA; Duffy SW; Chen TH
    Eur J Radiol; 2022 Aug; 153():110363. PubMed ID: 35605334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mammographic casting-type calcifications is not a prognostic factor in unifocal small invasive breast cancer: a population-based retrospective cohort study.
    Månsson E; Bergkvist L; Christenson G; Persson C; Wärnberg F
    J Surg Oncol; 2009 Dec; 100(8):670-4. PubMed ID: 19771563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mammographic tumor features can predict long-term outcomes reliably in women with 1-14-mm invasive breast carcinoma.
    Tabar L; Tony Chen HH; Amy Yen MF; Tot T; Tung TH; Chen LS; Chiu YH; Duffy SW; Smith RA
    Cancer; 2004 Oct; 101(8):1745-59. PubMed ID: 15386334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic role of HER2 expression in ductal breast carcinoma in situ (DCIS); a population-based cohort study.
    Borgquist S; Zhou W; Jirström K; Amini RM; Sollie T; Sørlie T; Blomqvist C; Butt S; Wärnberg F
    BMC Cancer; 2015 Jun; 15():468. PubMed ID: 26062614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoductgenesis in Ductal Carcinoma In Situ Coexists with Morphological Abnormalities Characteristic for More Aggressive Tumor Biology.
    Łazarczyk A; Streb J; Hałubiec P; Streb-Smoleń A; Jach R; Hodorowicz-Zaniewska D; Łuczyńska E; Szpor J
    Diagnostics (Basel); 2023 Feb; 13(4):. PubMed ID: 36832275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Casting-type calcifications with invasion and high-grade ductal carcinoma in situ: a more aggressive disease?
    Zunzunegui RG; Chung MA; Oruwari J; Golding D; Marchant DJ; Cady B
    Arch Surg; 2003 May; 138(5):537-40. PubMed ID: 12742959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lesion size is a major determinant of the mammographic features of ductal carcinoma in situ: findings from the Sloane project.
    Evans A; Clements K; Maxwell A; Bishop H; Hanby A; Lawrence G; Pinder SE;
    Clin Radiol; 2010 Mar; 65(3):181-4. PubMed ID: 20152272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Casting-type calcifications on the mammogram suggest a higher probability of early relapse and death among high-risk breast cancer patients.
    Pálka I; Ormándi K; Gaál S; Boda K; Kahán Z
    Acta Oncol; 2007; 46(8):1178-83. PubMed ID: 17851833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mammographic appearance of nonpalpable breast cancer reflects pathologic characteristics.
    Gajdos C; Tartter PI; Bleiweiss IJ; Hermann G; de Csepel J; Estabrook A; Rademaker AW
    Ann Surg; 2002 Feb; 235(2):246-51. PubMed ID: 11807365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clonal alteration of breast cancer receptors between primary ductal carcinoma in situ (DCIS) and corresponding local events.
    Karlsson E; Sandelin K; Appelgren J; Zhou W; Jirström K; Bergh J; Wärnberg F
    Eur J Cancer; 2014 Feb; 50(3):517-24. PubMed ID: 24275214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Higher density of stromal M2 macrophages in breast ductal carcinoma in situ predicts recurrence.
    Chen XY; Thike AA; Md Nasir ND; Koh VCY; Bay BH; Tan PH
    Virchows Arch; 2020 Jun; 476(6):825-833. PubMed ID: 31897820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mammographic morphology and distribution of calcifications in ductal carcinoma in situ diagnosed in organized screening.
    Hofvind S; Iversen BF; Eriksen L; Styr BM; Kjellevold K; Kurz KD
    Acta Radiol; 2011 Jun; 52(5):481-7. PubMed ID: 21498306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspects in mammographic screening. Detection, prediction, recurrence and prognosis.
    Thurfjell MG
    Acta Radiol Suppl; 2001 Dec; 42(424):1-22. PubMed ID: 12040855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stromal architecture and periductal decorin are potential prognostic markers for ipsilateral locoregional recurrence in ductal carcinoma in situ of the breast.
    Van Bockstal M; Lambein K; Gevaert O; De Wever O; Praet M; Cocquyt V; Van den Broecke R; Braems G; Denys H; Libbrecht L
    Histopathology; 2013 Oct; 63(4):520-33. PubMed ID: 23889174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between imaging and pathology in ductal carcinoma in situ of the breast.
    De Roos MA; Pijnappel RM; Post WJ; De Vries J; Baas PC; Groote LD
    World J Surg Oncol; 2004 Mar; 2():4. PubMed ID: 15018618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Qualitative Radiogenomics: Association Between BI-RADS Calcification Descriptors and Recurrence Risk as Assessed by the Oncotype DX Ductal Carcinoma In Situ Score.
    Woodard GA; Price ER
    AJR Am J Roentgenol; 2019 Apr; 212(4):919-924. PubMed ID: 30714832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of nuclear grade and immunohistochemical features in situ and invasive components of ductal carcinoma of breast.
    Aguiar FN; Mendes HN; Bacchi CE; Carvalho FM
    Rev Bras Ginecol Obstet; 2013 Mar; 35(3):97-102. PubMed ID: 23538467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening mammography-detected ductal carcinoma in situ: mammographic features based on breast cancer subtypes.
    Kim MY; Kim HS; Choi N; Yang JH; Yoo YB; Park KS
    Clin Imaging; 2015; 39(6):983-6. PubMed ID: 26259866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.